Comments on: Friday Q&A: Russell Greig of GlaxoSmithKline’s SR One

By: Technically Philly » Shop Talk: Interphase Systems CEO John Biglin on Ready-IT BioPharma | Covering the Community of People Who Use Technology in Philadelphia.

Wed, 09 Dec 2009 17:06:46 +0000

[...] One chief Russel Grieg told us he’s always been “disappointed” by biomedical entrepreneurship in Philadelphia, something others have cautiously echoed. NuPathe [...]

By: Timothy J. Webber, Ph.D.

Timothy J. Webber, Ph.D. — Sat, 17 Oct 2009 16:32:59 +0000

Dr. Greig was a Post-Doctoral Fellow when I met him in the 1980′s. He was dynamic, success-oriented and hard-working; someone you wanted on your team. His contribution to medical science focused on cancer chemotherapy. We have all benefited from his dedication. It looks like he will never change; just get better. Cheers!

By: Technically Philly » Friday Q&A: Jane Hollingsworth of NuPathe on Zelrix, migraines and more | Covering the Community of People Who Use Technology in Philadelphia.

Fri, 18 Sep 2009 18:42:00 +0000

[...] that you’ve brought that up, last month I spoke to Russel Grieg, the CEO of SR One, GlaxoSmithKline’s biomedical venture capital firm which has invested in NuPathe. He said he [...]

By: Technically Philly » Friday Q&A: Fran Hollingsworth of NuPathe on Zelrix, migraines and more | Covering the Community of People Who Use Technology in Philadelphia.

Fri, 18 Sep 2009 15:32:01 +0000

[...] that you’ve brought that up, last month I spoke to Russel Grieg, the CEO of SR One, GlaxoSmithKline’s biomedical venture capital firm which has invested in NuPathe. He said he [...]

By: Technically Philly » Friday Tech Links: Nicole Brewer gets 20 questions, Daring Fireball gets praise and More | Covering the Community of People Who Use Technology in Philadelphia.

Fri, 14 Aug 2009 12:31:20 +0000

[...] The Business Journal reports that Nupathe, the Conshohocken-based specialty pharmaceutical company, reported positive results from a trial of its migraine headache patch. GlaxoSmithKline venture capital arm SR One invested in the firm last year, as was recently discussed in our conversation with SR One’s CEO. [...]